Kingsview Wealth Management, LLC Abbott Laboratories Transaction History

Kingsview Wealth Management, LLC

$4.45 Billion
Q3 2024

A detailed history of Kingsview Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 78,067 shares of ABT stock, worth $9.05 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

78,067

Previous 78,360 0.37%

Holding current value

$9.05 Million

Previous $8.14 Million 9.31%

% of portfolio

0.2%

Previous 0.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $29,320 - $34,612	-293 Reduced 0.37%	78,067 $8.9 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $180,205 - $201,155	1,789 Added 2.34%	78,360 $8.14 Million
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $120,033 - $132,572	1,096 Added 1.45%	76,571 $8.7 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $337,851 - $413,558	-3,746 Reduced 4.73%	75,475 $8.31 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $174,819 - $209,754	1,830 Added 2.36%	79,221 $7.67 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $296,595 - $330,469	-2,943 Reduced 3.66%	77,391 $8.44 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $7,264 - $8,550	-75 Reduced 0.09%	80,334 $8.13 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $2.44 Million - $2.86 Million	-25,657 Reduced 24.19%	80,409 $8.83 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $438,322 - $507,495	4,530 Added 4.46%	106,066 $10.3 Million
Q2 2022 Aug 16, 2022	BUY	$102.07 - $123.37 $295,288 - $356,909	2,893 Added 2.93%	101,536 $11 Million
Q1 2022 Feb 08, 2024	BUY	$114.02 - $139.04 $3.56 Million - $4.34 Million	31,240 Added 41.39%	106,715 $12.6 Million
Q4 2021 Feb 17, 2022	BUY	$115.53 - $141.46 $543,915 - $665,993	4,708 Added 5.01%	98,643 $13.9 Million
Q3 2021 Dec 03, 2021	BUY	$116.66 - $129.06 $503,854 - $557,410	4,319 Added 4.82%	93,935 $11.1 Million
Q2 2021 Aug 17, 2021	BUY	$105.79 - $124.53 $385,498 - $453,787	3,644 Added 4.24%	89,616 $10.5 Million
Q1 2021 May 24, 2021	SELL	$108.84 - $128.23 $287,119 - $338,270	-2,638 Reduced 2.98%	85,972 $10.2 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $349,230 - $380,560	3,326 Added 3.9%	88,610 $9.7 Million
Q3 2020 Nov 19, 2020	SELL	$91.64 - $111.29 $35,647 - $43,291	-389 Reduced 0.45%	85,284 $9.28 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $34,762 - $44,492	454 Added 0.53%	85,673 $7.83 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $1.26 Million - $1.84 Million	20,002 Added 30.67%	85,219 $6.73 Million
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $4.38 Million - $4.87 Million	55,771 Added 590.42%	65,217 $5.67 Million
Q4 2019 Jan 30, 2020	SELL	$78.51 - $87.4 $3.49 Million - $3.89 Million	-44,486 Reduced 82.49%	9,446 $539,000
Q3 2019 Jan 29, 2020	BUY	$81.84 - $88.74 $167,117 - $181,207	2,042 Added 3.94%	53,932 $4.51 Million
Q2 2019 Jan 29, 2020	BUY	$72.88 - $85.0 $11,296 - $13,175	155 Added 0.3%	51,890 $4.36 Million
Q1 2019 Jan 29, 2020	BUY	$66.22 - $80.06 $194,289 - $234,896	2,934 Added 6.01%	51,735 $4.14 Million
Q4 2018 Jan 29, 2020	BUY	$65.56 - $74.27 $16,717 - $18,938	255 Added 0.53%	48,801 $3.53 Million
Q3 2018 Jan 29, 2020	BUY	$60.81 - $73.36 $3,526 - $4,254	58 Added 0.12%	48,546 $3.56 Million
Q2 2018 Jan 29, 2020	BUY	$57.57 - $63.54 $45,365 - $50,069	788 Added 1.65%	48,488 $2.96 Million
Q1 2018 Jan 29, 2020	BUY	$56.27 - $63.62 $2.15 Million - $2.43 Million	38,254 Added 404.98%	47,700 $2.86 Million
Q4 2017 Jan 29, 2020	BUY	$53.68 - $57.47 $292,394 - $313,039	5,447 Added 136.21%	9,446 $539,000
Q3 2017 Jan 29, 2020	BUY	$48.06 - $53.64 $192,191 - $214,506	3,999	3,999 $213,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Account

Kingsview Wealth Management, LLC Abbott Laboratories Transaction History